Cyclophosphamide and Pulmonary tuberculosis aggravated - a phase IV clinical study of FDA data
Summary:
Pulmonary tuberculosis aggravated is reported as a side effect among people who take Cyclophosphamide (cyclophosphamide), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Prednisone, and have Chronic lymphocytic leukaemia.
The phase IV clinical study analyzes which people have Pulmonary tuberculosis aggravated when taking Cyclophosphamide. It is created by eHealthMe based on reports of 185,094 people who have side effects when taking Cyclophosphamide from the FDA, and is updated regularly.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.
What is Pulmonary tuberculosis aggravated?
Pulmonary tuberculosis aggravated (serious lungs tuberculosis) is found to be associated with 355 drugs and 227 conditions by eHealthMe. Check the latest studies of Pulmonary tuberculosis aggravated.
185,094 people reported to have side effects when taking Cyclophosphamide.
Among them, 134 people (0.07%) have Pulmonary tuberculosis aggravated.
Among these 134 people:
How long have people been on Cyclophosphamide when they have Pulmonary tuberculosis aggravated? *
What is the gender of people who have Pulmonary tuberculosis aggravated when taking Cyclophosphamide? *
What is the age of people who have Pulmonary tuberculosis aggravated when taking Cyclophosphamide? *
What are other drugs people take besides Cyclophosphamide? *
What are other side effects people have besides Pulmonary tuberculosis aggravated? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Cyclophosphamide and have Pulmonary tuberculosis aggravated?
- Check whether Pulmonary tuberculosis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Cyclophosphamide:
- Cyclophosphamide (185,240 reports)
Pulmonary tuberculosis aggravated treatments and more:
- Pulmonary tuberculosis aggravated (10 reports)
How severe was Pulmonary tuberculosis aggravated and when was it recovered:
Expand to all the drugs that have ingredients of cyclophosphamide:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Pulmonary tuberculosis aggravated:
- Pulmonary tuberculosis aggravated (355 drugs)
Browse all the conditions that are associated with Pulmonary tuberculosis aggravated:
- Pulmonary tuberculosis aggravated (227 conditions)
Related publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on cyclophosphamide (the active ingredients of Cyclophosphamide) and Cyclophosphamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Humira cause Steatorrhea? - 40 seconds ago
- Drug interactions of Triamterene And Hydrochlorothiazide and Metformin - a minute ago
- Could Norlutate cause Weight Increased? - a minute ago
- Acetaminophen and Oedema Mucosal for Men aged 60+ - a minute ago
- Nuclear Magnetic Resonance Imaging Abdominal and Joint Contracture - a minute ago
- Cardizem Cd vs. Hydrodiuril, side effect and effectiveness comparison - a minute ago
- Anorexia and drugs of ingredients of ethosuximide - a minute ago
- How effective is Thalomid for Multiple Myeloma? - a minute ago
- Could Enbrel cause Chronic Myeloid Leukaemia? - a minute ago
- Could Buspirone Hcl cause Aggression? - 2 minutes ago